A preparation method of methocarbamol degradation derivative
Through the reaction of guaiacol glycerol ether with triphenyl chloride and dicarbonyl imidazole, combined with acid deprotection, the lengthy, numerous by-products and purification problems of the existing mesobamo synthesis method are solved, and high efficiency is achieved. Low-cost Mesobamo degraded derivative preparations provide suitable standard products for mass production and quality control.
Patent Information
- Application Number
- CN202310790122.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-30
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2043-06-30
AI Technical Summary
The existing Mesobamo synthesis method has long routes, many reaction by-products, poor selectivity, difficulty in purification, and the use of phosgene in the regulated product, resulting in high costs and complex production.
The reaction of guaiacol glycerol ether with triphenyl chloride to produce compound B, followed by nucleophilic substitution reaction with dicarbonyimidazole, and finally deprotection under the action of acid to obtain mesobamo degraded derivatives, avoiding the use of phosgene, Simplify steps and increase selectivity.
Efficient, low-cost and simple preparation of Mesobamo degraded derivatives is achieved, reducing by-products, simplifying the purification process, reducing costs, and providing suitable standard products for large-scale production and quality control.
Smart Images

Figure CN116768762B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for preparing a methocarbamol degradation derivative, and belongs to the field of biomedicine. Background Art
[0002] Methocarbamol tablets are a central muscle relaxant that can inhibit synaptic reflexes related to skeletal muscle spasms, have anti-convulsion effects caused by strychnine and electrical stimulation, and can also exert analgesic and anti-inflammatory effects. It is mainly used to treat joint and muscle sprains, lumbar muscle strain, sciatica and other diseases.
[0003]
[0004] The article "Study on the Impurity Spectrum and Degradation Pathway of Methocarbamol" published by Zhejiang Provincial Institute of Food and Drug Inspection details the degradation pathway of the impurity and its significance in drug quality research. The article records that compound E is a key impurity that occurs during the synthesis of methocarbamol, the degradation of raw materials or preparations, and its structure is as follows:
[0005]
[0006] The synthesis routes found through the synthesis literature search engines Reaxys and Scifinder mainly use regulated reaction reagents such as monophosgene or triphosgene, acetic anhydride, etc., and the post-processing is complicated. The synthesis steps are long and complicated, and the raw materials are difficult to source.
[0007] For example, the synthetic scheme described in [Monatshefte fur Chemie, 1963, vol. 94, p. 339-358] uses raw materials obtained through multi-step synthesis and is expensive.
[0008]
[0009] The route provided by Chinese patent CN106349112A is lengthy, has many reaction by-products, and uses phosgene, as follows:
[0010]
[0011] PFIZER INC-GB861960 provides a shorter route but poor product selectivity and difficult purification. The main product is methocarbamol. The specific route is as follows:
[0012]
[0013] In summary, the prior art method for synthesizing compound E faces the following problems: the route is lengthy, there are many reaction by-products, phosgene is used, the selectivity is poor, and subsequent purification is difficult. Summary of the invention
[0014] Purpose of the Invention
[0015] The purpose of the present invention is to provide a new, efficient, low-cost, simple and environmentally friendly method for preparing a degradation derivative of methocarbamol. The target product obtained can be used as a standard product of the degradation derivative of methocarbamol, and can also provide qualified process impurity reference products or degradation derivative standards of raw material preparations for methocarbamol raw material drug manufacturers and preparation manufacturers.
[0016] Technical Solution
[0017] A method for preparing a methocarbamol degradation derivative comprises the following steps:
[0018]
[0019] Step 1, synthesis of compound B:
[0020] Guaifenesin glycerol ether (Compound A) is dissolved in an organic solvent, an organic base and a catalyst are added at room temperature, and the mixture is reacted with triphenylmethane. After the reaction is completed as detected by TLC, the mixture is poured into water, extracted with ethyl acetate, washed, dried, and concentrated to obtain Compound B.
[0021] The molar ratio of guaiacol glycerol ether (compound A) (compound A) to triphenylmethane is 1:1 to 1:5, the organic base is triethylamine or N,N-diisopropylethylamine, preferably triethylamine; the reaction solvent is dichloromethane, tetrahydrofuran, ethyl acetate, chloroform, 2-methyltetrahydrofuran, preferably dichloromethane; the reaction catalyst is 4-N, N-lutidine; the reaction temperature is 0-40°C, preferably 20-40°C.
[0022] Step 2, synthesis of compound D:
[0023] Compound B is dissolved in an organic solvent and reacts with dicarbonyl imidazole for nucleophilic substitution at room temperature to generate compound C. After the reaction is completed by TLC detection, ammonia water is added to the reaction system and heated for reaction. After the reaction is completed by TLC monitoring, the system is concentrated to dryness, water is added, and the system is extracted with ethyl acetate, washed, dried, and concentrated to dryness to obtain compound D.
[0024] The molar ratio of compound B to carbonyldiimidazole is 1:1-1:1.5; the organic solvent is tetrahydrofuran, 2-methyltetrahydrofuran, ethylene glycol dimethyl ether, ethylene glycol monomethyl ether, preferably tetrahydrofuran; the reaction temperature is 0-40°C, preferably 20-30°C.
[0025] The ratio of compound C to aqueous ammonia is 1:10-1:50, preferably 1:10; the synthesis reaction temperature of compound D is 25-100°C, preferably 40-60°C.
[0026] Step 3: Synthesis of degradation derivative E:
[0027] Compound D was dissolved in an organic solvent, and an acid was added to heat the reaction for deprotection. After the reaction was completed by TLC, the solvent was removed by concentration under reduced pressure, and the mixture was extracted with ethyl acetate. The mixture was washed, dried, and filtered. The filtrate was concentrated to dryness and then slurried with tert-methyl ether and dichloromethane (3V:1V) to obtain the pure product.
[0028] The molar ratio of D to the acid is 1:1-1:10, preferably 1:5; the organic solvent is tetrahydrofuran, 2-methyltetrahydrofuran, methanol, dioxane, etc., preferably; the acid is hydrochloric acid, sulfuric acid, phosphoric acid, trifluoroacetic acid, acetic acid, etc., preferably hydrochloric acid; the reaction temperature is 20-60°C, preferably 20-40°C.
[0029] Beneficial Effects
[0030] 1. The present invention provides a new, efficient and simple method for preparing a degradation derivative of methocarbamol, which avoids the use of regulatory reagents, has the advantages of easy availability of reaction raw materials, short steps, high yield, simple purification, less waste, large-scale production, and a single operation in a short time to meet the large market demand for the degradation derivative standard or reference substance.
[0031] For this purpose, the inventors adopted a special synthetic route to achieve directional synthesis, and at the same time, the yield was high and it was easy to purify. In particular, in step one, a large steric hindrance triphenylmethane was used to selectively protect the primary hydroxyl group, and no secondary hydroxyl protection byproducts were produced, completing 100% group directional conversion; in step two, when dicarbonyl imidazole was used for nucleophilic substitution reaction to produce compound C, due to the difference in the activity of the leaving group, directional substitution can be achieved, so that the imidazole can be directly removed by ammonia reaction. However, common knowledge in the art generally believes that dicarbonyl imidazole substitution is an unstable system, especially an ester structure, and a stable imidazole intermediate structure (compound C) cannot be formed. But in fact, the inventors surprisingly found that dicarbonyl imidazole substitution is very stable. Only in the presence of a large amount of ammonia can the imidazole structure be removed without rearrangement, and compound C can be formed in a directional manner.
[0032] 2. The degradation derivative has the triple properties of process impurities and the largest impurities of API and preparation degradation. It is a scarce impurity in the market and is relatively expensive. The present invention uses common synthetic reagents and avoids the use of special reagents such as phosgene. It has a mild reaction and a low price (about one-tenth or lower of the market price), which solves the bottleneck technology of impurity synthesis and finds a better imported or domestic alternative. The degradation derivative standard or reference substance prepared by the preparation method is of great significance to the API and intermediate production control of methocarbamol and the quality control of the preparation. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 This is the HPLC result;
[0034] Figure 2 is the mass spectrum corresponding to the retention time of 2.667;
[0035] Figure 3 The mass spectrum corresponding to the retention time of 2.950;
[0036] Figure 4 The hydrogen spectrum result of compound E is shown in FIG. DETAILED DESCRIPTION
[0037] Example 1
[0038] Step 1: Add guaiacol glycerol ether (compound A, 10.0 g, 50.5 mmol) to a 100 mL single-mouth bottle, dissolve it with dichloromethane (100 mL), add triethylamine (13.0 g, 129 mmol), 4-N, N-dimethylpyridine (0.10 g, 0.82 mmol), triphenylmethane (16.8 g, 60.3 mmol), and react at 25 ° C. After TLC monitoring until the reaction is completed, pour it into water to quench, extract it with ethyl acetate (100 mL*3), wash with tap water (50 ml*2), let it stand fully, and then concentrate it directly to dryness to obtain an off-white compound B (16.8 g, 100%).
[0039] Step 2: Compound B (7.70 g, 17.5 mmol) was added to a 50 mL three-necked flask, dissolved with tetrahydrofuran (110 mL), and carbonyldiimidazole (3.40 g, 21.0 mmol) was added for reaction. After TLC monitoring until the reaction starting materials disappeared, ammonia water (22.3 g, 159 mmol) was added and reacted at 40 ° C. After TLC monitoring, the reaction was complete, the solvent was concentrated and poured into tap water (100 mL). The residue was stirred and filtered, and dried to obtain an off-white solid compound D (7.40 g, 88%).
[0040] Step 3: Add compound D (7.40 g, 15.3 mmol) and tetrahydrofuran (71 mL) to a 250 mL three-necked flask, add hydrochloric acid (4 M, 35 mL) after dissolving, and react at room temperature for half an hour. After the reaction is complete, the reaction solution is spin-dried, extracted with ethyl acetate (100 mL*3), washed, dried and filtered, and the filtrate is concentrated and slurried with tert-methyl ether and dichloromethane (30 mL:10 mL) to obtain pure compound E (2.50 g, 68%).
[0041] ESI-MS (m / z): 241.2;
[0042] 1H NMR (400MHz, DMSO) δ7.05-6.93(t,2H),6.93-6.82(m,2H),6.51(s,2H),4.93-4.78(m,2H),4.20-3.95(m,2H),3.75(s,3H),3.65-3.55(t,2H).
[0043] Example 2
[0044] Step 1: Add 1 (100 g, 505 mmol) to a 2L three-necked flask, dissolve it with dichloromethane (1 L), then add triethylamine (130 g, 1.3 mol), 4-N,N-dimethylpyridine (2.00 g, 16.4 mmol), triphenylmethane (168 g, 0.6 mol), and react at 25°C. After TLC monitoring, pour it into water to quench the reaction, extract it with ethyl acetate (1000 mL*3), wash it with tap water (500 ml*2), let it stand sufficiently, and then concentrate it to dryness to obtain an off-white compound B (165 g, 98%).
[0045] Step 2: Add compound B (165 g, 375 mmol) to a 2L three-necked flask, dissolve it with 2-methyltetrahydrofuran (1.5 L), add carbonyldiimidazole (72.9 g, 450 mmol) to react, monitor by TLC until the reaction raw materials disappear, add ammonia water (525 g, 3.75 mol), react at 40 ° C, monitor by TLC until the reaction is complete, concentrate to remove the solvent, pour the residue into tap water (1000 mL), filter after stirring, and dry to obtain an off-white solid compound D (159 g, 90%).
[0046] Step 3: Add compound D (159 g, 338 mmol) and tetrahydrofuran (1.5 L) into a 2 L three-necked flask, add hydrochloric acid (4 M, 845 mL) after dissolving, and react at 40 ° C for half an hour. After the reaction is complete, the reaction solution is spin-dried, extracted with ethyl acetate (1.5 L * 3), washed, dried and filtered, and the filtrate is concentrated and slurried with tert-methyl ether and dichloromethane (600 mL: 100 mL) to obtain compound E (61.0 g, 75%).
[0047] ESI-MS (m / z): 241.2;
[0048] 1 H NMR (400MHz, DMSO) δ7.05-6.93(t,2H),6.93-6.82(m,2H),6.51(s,2H),4.93-4.78(m,2H),4.20-3.95(m,2H),3.75(s,3H),3.65-3.55(t,2H).
Claims
1. A method for preparing a methocarbamol degradation derivative, characterized in that Follow these steps to achieve this: The following steps are involved: Step 1, synthesis of compound B: Guaifenesin glycerol ether A is dissolved in an organic solvent, an organic base and a catalyst are added at room temperature, and the mixture is reacted with triphenylmethane. After the reaction is completed by TLC detection, the mixture is poured into water, extracted with ethyl acetate, and washed. Drying and concentration to obtain compound B, Step 2, synthesis of compound D: Compound B was dissolved in an organic solvent and reacted with carbonyl diimidazole to generate compound C at room temperature. After the reaction was completed, ammonia water was added to the reaction system and heated for reaction. After the reaction is completed, the mixture is concentrated to dryness, water is added, and the mixture is extracted with ethyl acetate, washed, dried, and concentrated to dryness to obtain compound D; Step 3: Synthesis of degradation derivative E: Dissolve compound D in an organic solvent, add acid and heat to react and deprotect. After the reaction is completed by TLC, remove the solvent by concentration under reduced pressure, extract with ethyl acetate, wash, dry and filter. After the filtrate is concentrated to dryness, methyl tert-ether and dichloromethane are mixed in a volume ratio of 3:1 to obtain a pure product. Wherein: in step 1, the molar ratio of guaiacol glycerol ether A to triphenylmethane is 1:1-1:5, the organic base is triethylamine or N,N-diisopropylethylamine, the reaction solvent is dichloromethane, tetrahydrofuran, ethyl acetate, chloroform or 2-methyltetrahydrofuran; the reaction catalyst is 4-dimethylaminopyridine; and the reaction temperature is 0-40°C.
2. The method according to claim 1, characterized in that In step 2, the molar ratio of compound B to carbonyl diimidazole is 1:1-1:1.5; the organic solvent is tetrahydrofuran, 2-methyltetrahydrofuran, ethylene glycol dimethyl ether or ethylene glycol monomethyl ether; and the reaction temperature is 0-40°C.
3. The method according to claim 1, characterized in that In step 2, the molar ratio of compound C to aqueous ammonia is 1:10-1:50; the synthesis reaction temperature of compound D is 25-100°C.
4. The method according to claim 1, characterized in that: In step 3, the molar ratio of compound D to acid is 1:1-1:10; the organic solvent is tetrahydrofuran, 2-methyltetrahydrofuran, methanol or dioxane; the acid is hydrochloric acid, sulfuric acid, phosphoric acid or trifluoroacetic acid or acetic acid; and the reaction temperature is 20-60°C.
Citation Information
Patent Citations
Herbicide for apple orchard
CN105532688A
Preparation method of methocarbamol beta isomer
CN106349112A
Methocarbamol compositions and related methods
US20230107569A1
